Insider · CIK 0001861989

Lehr Martin A.

Reports to the SEC for 1 company · PHILADELPHIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001861989

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-19	CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+815K sh	—	—	815,000
2025-06-09	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+100K sh	$0.70	+$70.1K	920,190
2025-02-13	CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+803K sh	—	—	802,700
2024-03-21	CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+291K sh	—	—	291,402
2023-02-21	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,823 sh	$0.84	+$4,900.055	159,701
2023-02-13	CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+288K sh	—	—	287,544
2023-02-13	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,606 sh	$0.87	+$4,900.765	153,878
2023-02-06	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,040 sh	$0.97	+$4,900.392	148,272
2023-01-30	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+7,027 sh	$0.70	+$4,900.63	143,232
2023-01-23	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+6,839 sh	$0.72	+$4,900.827	136,205
2023-01-17	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+6,783 sh	$0.74	+$4,995.001	129,366
2022-12-16	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+20K sh	$0.74	+$14.8K	122,583
2022-08-19	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+13K sh	$1.85	+$24.1K	102,583
2022-02-25	CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+254K sh	—	—	254,300
2021-12-16	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+13K sh	$3.22	+$41.8K	820,190
2021-10-22	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$5.00	+$50K	99,583
2021-10-22	CNTXContext Therapeutics Inc.O Exercise Out-of-Money	Director, Chief Executive Officer	OExercise Out-of-Money	+52.7K sh	$7.14	+$376K	52,680
2021-10-22	CNTXContext Therapeutics Inc.C Conversion	Director, Chief Executive Officer	CConversion	+211K sh	—	—	263,402
2021-10-22	CNTXContext Therapeutics Inc.C Conversion	Director, Chief Executive Officer	CConversion	+586K sh	—	—	849,878
2021-10-22	CNTXContext Therapeutics Inc. · Warrant (right to buy)O Exercise Out-of-Money	Director, Chief Executive Officer	OExercise Out-of-Money	+52.7K sh	—	—	0
2021-10-22	CNTXContext Therapeutics Inc. · Series A Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−211K sh	—	—	0
2021-10-22	CNTXContext Therapeutics Inc. · Series Seed Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−586K sh	—	—	0
2021-10-22	CNTXContext Therapeutics Inc.O Exercise Out-of-Money	Director, Chief Executive Officer	OExercise Out-of-Money	+52.7K sh	$7.14	+$376K	0
2021-10-22	CNTXContext Therapeutics Inc.C Conversion	Director, Chief Executive Officer	CConversion	+211K sh	—	—	210,715
2021-10-22	CNTXContext Therapeutics Inc.C Conversion	Director, Chief Executive Officer	CConversion	+586K sh	—	—	797,190
2021-10-22	CNTXContext Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$5.00	+$50K	807,190
2021-10-22	CNTXContext Therapeutics Inc. · Warrant (right to buy)O Exercise Out-of-Money	Director, Chief Executive Officer	OExercise Out-of-Money	+52.7K sh	—	—	0
2021-10-22	CNTXContext Therapeutics Inc. · Series A Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−211K sh	—	—	7
2021-10-22	CNTXContext Therapeutics Inc. · Series Seed Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−586K sh	—	—	1

Recent filings

Accepted (ET)
Feb 234
Lehr Martin A.0001628280-26-010616
SEC(opens sec.gov)
Jun 104
Lehr Martin A.0001842952-25-000064
SEC(opens sec.gov)
Feb 144
Lehr Martin A.0001842952-25-000019
SEC(opens sec.gov)
Mar 224
Lehr Martin A.0001842952-24-000017
SEC(opens sec.gov)
Feb 214
Lehr Martin A.0001842952-23-000030
SEC(opens sec.gov)
Feb 144
Lehr Martin A.0001842952-23-000027
SEC(opens sec.gov)
Feb 134
Lehr Martin A.0001842952-23-000020
SEC(opens sec.gov)
Feb 64
Lehr Martin A.0001842952-23-000017
SEC(opens sec.gov)
Jan 304
Lehr Martin A.0001842952-23-000012
SEC(opens sec.gov)
Jan 234
Lehr Martin A.0001842952-23-000008
SEC(opens sec.gov)
Jan 184
Lehr Martin A.0001842952-23-000006
SEC(opens sec.gov)
Dec 194
Lehr Martin A.0001842952-22-000112
SEC(opens sec.gov)
Aug 224
Lehr Martin A.0001842952-22-000081
SEC(opens sec.gov)
Feb 254
Lehr Martin A.0001842952-22-000018
SEC(opens sec.gov)
Dec 204
Lehr Martin A.0001842952-21-000029
SEC(opens sec.gov)
Dec 174/A
Lehr Martin A.0001842952-21-000027
SEC(opens sec.gov)

Companies

Context Therapeutics Inc.Director, Chief Executive OfficerCNTX

Address

2001 MARKET STREET SUITE 3915, UNIT #15

PHILADELPHIA, PA, 19103